Doron Adler, PhD

Dr. Adler is a serial entrepreneur with an impressive track record in establishing successful med-tech companies.

Prior to founding Sanolla, Dr. Adler was the founder and CEO of Cbyond for 15 years until it was acquired by Olympus  for $2.1B. During this time he transitioned into the role of CEO of Olympus Israel and CTO for Olympus Surgical US.

Dr. Adler began his start-up career as the founder of iSight and was also part of the founding team and VP R&D of Given Imaging, later acquired by Covidien for $860M.

After his military service as a major in the Israeli Air Force he worked at Elbit – a leading global high-tech company.

Dr. Adler holds a Ph.D., M.Sc. and B.Sc. degrees in Electrical Engineering all from Technion – the Israel Institute of Technology. He has filed more than 130 patents, with most of these patents implemented in existing products.

Gideon Sturlesi

Mr. Sturlesi is a seasoned executive in the Life Science industry with “hands on” management experience. Among other, Mr. Sturlesi served as co-founder of Galil Medical Ltd.,  General Manger of Lumenis Vision and EVP of  the Corporate and Deputy Director in Rafael.  He was Co- founder and general partner of BioMedical Israel Ltd., a life-science private fund group. Mr. Sturlesi holds a BSc and MSc (cum-laude) from the Technion – Israel Institute of Technology and he is the co-author of several patents and scientific  publications.

Hadar Ron

Dr. Hadar Ron is the founding partner of Israel Healthcare Ventures (IHCV), one of the most successful Israeli healthcare Venture Capital Funds.

She has an extensive medical, legal and management experience gained in senior positions in the financial, insurance, legal, healthcare sectors.

Dr. Ron serves as an active chairman of the Board of several healthcare companies and is a board member of numerous others, both private and public.

Dr. Ron is involved in many social initiatives in Israel, chairs the scientific advisory board  of Social Finance Israel, served as a member of the Board of Yissum, the technology transfer

company of the Hebrew University in Jerusalem, as a member of the advisory Board of the Momentum Fund of Tel Aviv University, and currently serves as a board member of BIRAD the tech transfer company

of Bar Ilan University.

Dr. Ron is a physician and attorney by education. She holds MD and LLB degrees from Tel Aviv University and has studied at the School of Business Administration at Tel Aviv University

Dorit Sokolov

Dorit is a seasoned HealthTech executive with extensive experience in Innovation, Investments, Business Development, and Strategy.  She is an investor, entrepreneur and advisor, focusing on bioconvergence and care delivery. She also serves on the Board of Directors of Isorad, the commercialization arm of Soreq Nuclear Center, a government owned company, developing and marketing advanced electro-optical and nuclear medicine products. Previously Dorit was a Managing Director with aMoon fund, worked with Amgen, scouting globally for ‘Beyond the Molecule’ technologies, co-founded Sanara Ventures, held VP BD positions with medical technology startups, worked as a Principal with Evergreen Venture Partners, and worked as a consultant with McKinsey & Company. Dorit holds a Pharmacy degree from the Hebrew University in Jerusalem, and an MBA from the Kellogg School of Management both Cum Laude.

Prof. Shmuel Banai

Prof. Banai is one of Israel’s leading Cardiologists and a well-known researcher. Professor Banai leads a productive and busy career as both the Director of the Division of Cardiology and the Head of Interventional Cardiology at the Tel Aviv Souraski Medical Center, Tel Aviv, Israel and as the Medical Director for Neovasc Inc.

He is a full academic Professor of Cardiology at the Tel Aviv University, Sackler School of Medicine. Head, of the Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering, and the Walton Chair of Interventional Cardiology at the Tel Aviv University.

Professor Banai is the author of more than 200 peer-reviewed papers and book chapters and has participated in many clinical and pre-clinical research.